Do analysts prefer HIT or AIFF?

Health In Tech currently has a consensus target price of $3.50, suggesting a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health In Tech 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend AIFF or DRIO?

DarioHealth has a consensus price target of $10.00, suggesting a potential upside of 47.71%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts clearly believe DarioHealth is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 DarioHealth 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts recommend ONMD or AIFF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ACON or AIFF?

Aclarion currently has a consensus target price of $7.50, suggesting a potential upside of 212.50%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Firefly Neuroscience. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ITOC or AIFF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, ITOC or AIFF?

Itonic has higher earnings, but lower revenue than Firefly Neuroscience. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Itonic $520K 10.38 -$5.10M N/A N/A Firefly Neuroscience $1.14M 14.86 -$19.88M -$0.59 N/A

Firefly Neuroscience (AIFF) Competitors

$1.08 0.00 (0.00%)

As of 08/28/2026 04:00 PM Eastern

Compare

AIFF vs. HIT, DRIO, ONMD, ACON, and ITOC

Should you buy Firefly Neuroscience stock or one of its competitors? Firefly Neuroscience's main competitors and comparable companies include Health In Tech (HIT), DarioHealth (DRIO), OneMedNet (ONMD), Aclarion (ACON), and Itonic (ITOC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Firefly Neuroscience compare to Health In Tech?

Health In Tech (NASDAQ:HIT) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

Health In Tech has higher revenue and earnings than Firefly Neuroscience. Health In Tech is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.96	-$4.59M	-$0.07	N/A
Firefly Neuroscience	$1.14M	14.86	-$19.88M	-$0.59	N/A

In the previous week, Health In Tech had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for Health In Tech and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.89 beat Health In Tech's score of 1.26 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Health In Tech	Positive
Firefly Neuroscience	Very Positive

Health In Tech has a beta of 2.82, indicating that its stock price is 182% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Health In Tech has a net margin of 0.00% compared to Firefly Neuroscience's net margin of -506.23%. Health In Tech's return on equity of 0.00% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

5.0% of Firefly Neuroscience shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 6.9% of Firefly Neuroscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Health In Tech currently has a consensus target price of $3.50, suggesting a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Health In Tech beats Firefly Neuroscience on 13 of the 17 factors compared between the two stocks.

How does Firefly Neuroscience compare to DarioHealth?

Firefly Neuroscience (NASDAQ:AIFF) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

In the previous week, DarioHealth had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for DarioHealth and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.89 beat DarioHealth's score of 1.18 indicating that Firefly Neuroscience is being referred to more favorably in the media.

Company	Overall Sentiment
Firefly Neuroscience	Very Positive
DarioHealth	Positive

DarioHealth has a consensus price target of $10.00, suggesting a potential upside of 47.71%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts clearly believe DarioHealth is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

DarioHealth has a net margin of -169.87% compared to Firefly Neuroscience's net margin of -506.23%. DarioHealth's return on equity of -54.81% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Firefly Neuroscience	-506.23%	-90.17%	-72.05%
DarioHealth	-169.87%	-54.81%	-33.36%

Firefly Neuroscience has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, DarioHealth has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

5.0% of Firefly Neuroscience shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 6.9% of Firefly Neuroscience shares are owned by company insiders. Comparatively, 3.5% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Firefly Neuroscience has higher earnings, but lower revenue than DarioHealth. Firefly Neuroscience is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Firefly Neuroscience	$1.14M	14.86	-$19.88M	-$0.59	N/A
DarioHealth	$22.36M	2.97	-$41.71M	-$6.13	N/A

Summary

DarioHealth beats Firefly Neuroscience on 11 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to OneMedNet?

OneMedNet (NASDAQ:ONMD) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

Firefly Neuroscience has a net margin of -506.23% compared to OneMedNet's net margin of -584.20%. OneMedNet's return on equity of 0.00% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	-584.20%	N/A	-521.20%
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

OneMedNet has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market.

In the previous week, OneMedNet had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for OneMedNet and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.89 beat OneMedNet's score of 1.43 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Overall Sentiment
OneMedNet	Positive
Firefly Neuroscience	Very Positive

OneMedNet has higher revenue and earnings than Firefly Neuroscience. OneMedNet is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.36M	25.29	-$2.80M	-$0.16	N/A
Firefly Neuroscience	$1.14M	14.86	-$19.88M	-$0.59	N/A

1.0% of OneMedNet shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 50.2% of OneMedNet shares are held by insiders. Comparatively, 6.9% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

OneMedNet beats Firefly Neuroscience on 8 of the 13 factors compared between the two stocks.

How does Firefly Neuroscience compare to Aclarion?

Aclarion (NASDAQ:ACON) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

7.5% of Aclarion shares are owned by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are owned by institutional investors. 0.0% of Aclarion shares are owned by company insiders. Comparatively, 6.9% of Firefly Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Aclarion had 1 more articles in the media than Firefly Neuroscience. MarketBeat recorded 2 mentions for Aclarion and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.89 beat Aclarion's score of 0.43 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Aclarion	Neutral
Firefly Neuroscience	Very Positive

Aclarion has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market.

Aclarion currently has a consensus target price of $7.50, suggesting a potential upside of 212.50%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Firefly Neuroscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Firefly Neuroscience has a net margin of -506.23% compared to Aclarion's net margin of -10,948.81%. Aclarion's return on equity of -59.34% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,948.81%	-59.34%	-56.12%
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

Aclarion has higher earnings, but lower revenue than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	82.57	-$7.23M	-$7.40	N/A
Firefly Neuroscience	$1.14M	14.86	-$19.88M	-$0.59	N/A

Summary

Aclarion beats Firefly Neuroscience on 11 of the 16 factors compared between the two stocks.

How does Firefly Neuroscience compare to Itonic?

Itonic (NASDAQ:ITOC) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Itonic has a net margin of 0.00% compared to Firefly Neuroscience's net margin of -506.23%. Itonic's return on equity of 0.00% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

Itonic has higher earnings, but lower revenue than Firefly Neuroscience.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$520K	10.38	-$5.10M	N/A	N/A
Firefly Neuroscience	$1.14M	14.86	-$19.88M	-$0.59	N/A

Itonic has a beta of 2.81, meaning that its share price is 181% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

5.0% of Firefly Neuroscience shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Itonic had 10 more articles in the media than Firefly Neuroscience. MarketBeat recorded 11 mentions for Itonic and 1 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 1.89 beat Itonic's score of 0.17 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Itonic	Neutral
Firefly Neuroscience	Very Positive

Summary

Itonic beats Firefly Neuroscience on 6 of the 11 factors compared between the two stocks.

Get Firefly Neuroscience News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIFF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AIFF vs. The Competition

Export

Metric	Firefly Neuroscience	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$16.95M	$1.79B	$7.21B	$12.90B
Dividend Yield	N/A	4.69%	2.54%	11.28%
P/E Ratio	-1.83	21.60	273.16	25.42
Price / Sales	14.86	86.82	635.16	104.14
Price / Cash	N/A	31.93	28.74	36.03
Price / Book	1.89	6.31	11.08	6.36
Net Income	-$19.88M	-$18.66M	$3.48B	$349.79M
7 Day Performance	3.85%	2.82%	0.38%	-0.40%
1 Month Performance	0.93%	15.30%	7.89%	4.24%
1 Year Performance	-59.25%	-14.96%	24.71%	15.13%

Firefly Neuroscience Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AIFF Firefly Neuroscience	0.9089 of 5 stars	$1.08 flat	N/A	-59.2%	$16.95M	$1.14M	N/A	N/A
HIT Health In Tech	2.659 of 5 stars	$1.03 +3.0%	$3.50 +239.8%	-64.4%	$67.50M	$32.83M	N/A	79	Positive News
DRIO DarioHealth	4.0561 of 5 stars	$7.16 -0.3%	$10.00 +39.7%	-28.8%	$52.72M	$22.36M	N/A	200	Positive News
ONMD OneMedNet	1.6916 of 5 stars	$0.58 -2.9%	N/A	-32.6%	$35.60M	$1.36M	N/A	2	Positive News Short Interest Decrease Gap Up
ACON Aclarion	2.9676 of 5 stars	$2.77 +6.5%	$7.50 +170.8%	-66.5%	$7.49M	$80K	N/A	7	Positive News Short Interest Increase High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AIFF) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Firefly Neuroscience (AIFF) Competitors

AIFF vs. HIT, DRIO, ONMD, ACON, and ITOC

How does Firefly Neuroscience compare to Health In Tech?

Summary

How does Firefly Neuroscience compare to DarioHealth?

Summary

How does Firefly Neuroscience compare to OneMedNet?

Summary

How does Firefly Neuroscience compare to Aclarion?

Summary

How does Firefly Neuroscience compare to Itonic?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIFF vs. The Competition

Firefly Neuroscience Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Firefly Neuroscience (AIFF) Competitors

AIFF vs. HIT, DRIO, ONMD, ACON, and ITOC

How does Firefly Neuroscience compare to Health In Tech?

Which has stronger valuation and earnings, HIT or AIFF?

Does the media favor HIT or AIFF?

Which has more risk & volatility, HIT or AIFF?

Is HIT or AIFF more profitable?

Do insiders & institutionals hold more shares of HIT or AIFF?

Do analysts prefer HIT or AIFF?

Summary

How does Firefly Neuroscience compare to DarioHealth?

Does the media refer more to AIFF or DRIO?

Do analysts recommend AIFF or DRIO?

Is AIFF or DRIO more profitable?

Which has more risk & volatility, AIFF or DRIO?

Do insiders and institutionals hold more shares of AIFF or DRIO?

Which has higher earnings and valuation, AIFF or DRIO?

Summary

How does Firefly Neuroscience compare to OneMedNet?

Is ONMD or AIFF more profitable?

Do analysts recommend ONMD or AIFF?

Which has more volatility & risk, ONMD or AIFF?

Does the media favor ONMD or AIFF?

Which has better valuation and earnings, ONMD or AIFF?

Do insiders & institutionals hold more shares of ONMD or AIFF?

Summary

How does Firefly Neuroscience compare to Aclarion?

Do institutionals and insiders have more ownership in ACON or AIFF?

Does the media prefer ACON or AIFF?

Which has more volatility & risk, ACON or AIFF?

Do analysts rate ACON or AIFF?

Is ACON or AIFF more profitable?

Which has better earnings and valuation, ACON or AIFF?

Summary

How does Firefly Neuroscience compare to Itonic?

Is ITOC or AIFF more profitable?

Which has higher valuation and earnings, ITOC or AIFF?

Which has more risk and volatility, ITOC or AIFF?

Do analysts rate ITOC or AIFF?

Do institutionals & insiders have more ownership in ITOC or AIFF?

Does the media prefer ITOC or AIFF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIFF vs. The Competition

Firefly Neuroscience Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools